(6 intermediate revisions by 3 users not shown) | |||
Line 720: | Line 720: | ||
<div class="h1">Material</div> | <div class="h1">Material</div> | ||
− | <div class="h2"><b>1.</b>Bacteria Strains used in this work</div> | + | <div class="h2"><b>1. </b>Bacteria Strains used in this work</div> |
<table class="table table-bordered table-hover"> | <table class="table table-bordered table-hover"> | ||
<thead> | <thead> | ||
Line 734: | Line 734: | ||
<td><i>E.coli</i> trans-5α</td> | <td><i>E.coli</i> trans-5α</td> | ||
<td class="success">Basic strain of calcium conversion</td> | <td class="success">Basic strain of calcium conversion</td> | ||
− | <td class="success"> | + | <td class="success">Plasmid construction, molecular cloning</td> |
<td class="success">Purchase by Shanghai Weidi Biotechnology</td> | <td class="success">Purchase by Shanghai Weidi Biotechnology</td> | ||
</tr> | </tr> | ||
Line 747: | Line 747: | ||
<td class="success">Type strain</td> | <td class="success">Type strain</td> | ||
<td class="success">Phenotypic validation</td> | <td class="success">Phenotypic validation</td> | ||
− | <td class="success">Provide by Dr.Shan Li (Bio-Medical Center of HZAU)</td> | + | <td class="success">Provide by Dr. Shan Li (Bio-Medical Center of HZAU)</td> |
</tr> | </tr> | ||
<tr> | <tr> | ||
Line 757: | Line 757: | ||
<tr> | <tr> | ||
<td><i>S.</i> typhimurium SL1344 (<i>ΔsipD</i>)</td> | <td><i>S.</i> typhimurium SL1344 (<i>ΔsipD</i>)</td> | ||
− | <td class="success"> | + | <td class="success">Knockout Type III secretion system</td> |
<td class="success">Phenotypic validation</td> | <td class="success">Phenotypic validation</td> | ||
<td class="success">This work</td> | <td class="success">This work</td> | ||
Line 768: | Line 768: | ||
− | <div class="h2"><b>2.</b>Culture Condition</div> | + | <div class="h2"><b>2. </b>Culture Condition</div> |
<table class="table table-bordered table-hover"> | <table class="table table-bordered table-hover"> | ||
<thead> | <thead> | ||
Line 798: | Line 798: | ||
<div id="float02"> | <div id="float02"> | ||
<div class="h1">Method</div> | <div class="h1">Method</div> | ||
− | <div class="h2"><b>1.</b>Plasmid construction</div> | + | <div class="h2"><b>1. </b>Plasmid construction</div> |
<p>Our fragments was PCR amplified with KOD (TOYOBO<sup>®</sup>) or PrimeSTAR (Takara<sup>®</sup>) | <p>Our fragments was PCR amplified with KOD (TOYOBO<sup>®</sup>) or PrimeSTAR (Takara<sup>®</sup>) | ||
according to product length. <br><br> | according to product length. <br><br> | ||
Line 808: | Line 808: | ||
</p> | </p> | ||
− | <div class="h2"><b>2.</b>Transformation</div> | + | <div class="h2"><b>2. </b>Transformation</div> |
<p> | <p> | ||
1. Add 3-5μl plasmid to 50μl F-trans5α (Weidi Biotechnology) competent cells and incubate 5min in ice | 1. Add 3-5μl plasmid to 50μl F-trans5α (Weidi Biotechnology) competent cells and incubate 5min in ice | ||
Line 818: | Line 818: | ||
overnight at 37°C. And prepare PCR reaction to select individual bacterial colony. | overnight at 37°C. And prepare PCR reaction to select individual bacterial colony. | ||
</p> | </p> | ||
− | <div class="h2"><b>3.</b>Fluorescence/growth measurememt</div> | + | <div class="h2"><b>3. </b>Fluorescence/growth measurememt</div> |
<p> | <p> | ||
Cell are cultured overnight in LB broth containing corresponding antibiotics, and diluted to OD is | Cell are cultured overnight in LB broth containing corresponding antibiotics, and diluted to OD is | ||
Line 830: | Line 830: | ||
<div id="float03"> | <div id="float03"> | ||
<div class="h1">Modeling impact our experiment</div> | <div class="h1">Modeling impact our experiment</div> | ||
− | <p>The higher ATc level might | + | <p>The higher ATc level might thwart bacterial growth. So we need to analyze a proper concentration of |
ATc, We design a modeling to predict a suitable concentration of ATc (More result about our model | ATc, We design a modeling to predict a suitable concentration of ATc (More result about our model | ||
− | please check <a href="https://2018.igem.org/Team:HZAU-China/Model">modeling:Chemical control model</a>). | + | please check <a href="https://2018.igem.org/Team:HZAU-China/Model">modeling: Chemical control model</a>). |
We induced our engineered strain with gradients of ATc. Take 100μl culture to plate on LB agar | We induced our engineered strain with gradients of ATc. Take 100μl culture to plate on LB agar | ||
plates containing appropriate concentration of antibody after 5 minutes, 30 minutes, 90 minutes of | plates containing appropriate concentration of antibody after 5 minutes, 30 minutes, 90 minutes of | ||
− | induce and counting Colony Forming Units the next day. The | + | induce and counting Colony Forming Units the next day. The results fit the model within a range of |
ATc. So we choose a appropriate concentration of ATc (16μg/ml), aiming to maximize the expression of | ATc. So we choose a appropriate concentration of ATc (16μg/ml), aiming to maximize the expression of | ||
GSDMD-N275 and minimize the negative effect of bacteria growth. | GSDMD-N275 and minimize the negative effect of bacteria growth. |
Latest revision as of 03:57, 18 October 2018
Strain | Description | Usage | Sourse |
---|---|---|---|
E.coli trans-5α | Basic strain of calcium conversion | Plasmid construction, molecular cloning | Purchase by Shanghai Weidi Biotechnology |
E.coli MG1655 | Type strain | Phenotypic validation | Provide by Dr. Chenli Liu (SIAT CSynBER) |
S. typhimurium SL1344 | Type strain | Phenotypic validation | Provide by Dr. Shan Li (Bio-Medical Center of HZAU) |
S. typhimurium SL1344 (ΔsifA) | Decrease toxicity and infectivity | Phenotypic validation | This work |
S. typhimurium SL1344 (ΔsipD) | Knockout Type III secretion system | Phenotypic validation | This work |
Culture medium | Compositions |
Luria Broth (LB) | 0.5% yeast extraction,1% NaCl and 1% tryptone (add 15 g/L agar when prepare solid culture) |
Super Optimal Broth (SOB) | 0.5% yeast extraction, 0.05% NaCl and 2% tryptone (add 15 g/L agar when prepare solid culture) (add 5ml 2 mol/L MgCl2 before use) |
Our fragments was PCR amplified with KOD (TOYOBO®) or PrimeSTAR (Takara®)
according to product length.
Product is recycled with gel extraction kit from OMEGA® after electrophoresis.
ClonExpress® II One Step Cloning Kit (Vyzyme) was used to ligate every fragment to
construct the most plasmids.
All plasmid constructs were confirmed by sequencing at Sangon®, Inc. (Wuhan,China).
A single frozen glycerol stock was used throughout this study for each bacterial strain.
1. Add 3-5μl plasmid to 50μl F-trans5α (Weidi Biotechnology) competent cells and incubate 5min in ice
, coated plates, select monoclonal colony PCR. Add extra 42℃ heat shock 45s and incubate 10min step
will increase transformation efficiency.
Or 1.5kv, 4-5ms electroporate cell with 300-400 ng purified plasmid. Recover at 37°C 950 rpm for 1h.
2. Plated on LB agar plates containing appropriate concentration of antibody for selection, grown
overnight at 37°C. And prepare PCR reaction to select individual bacterial colony.
Cell are cultured overnight in LB broth containing corresponding antibiotics, and diluted to OD is
0.1 with fresh LB broth.
Expression was induced at early log phase by addition of different ATc (150 ng/ml–15μg/ml)
concentrations. Culture the plate in 37℃, 150 rpm. Every hour put it into a plate reader to
measure its fluorescence/OD1.
The higher ATc level might thwart bacterial growth. So we need to analyze a proper concentration of ATc, We design a modeling to predict a suitable concentration of ATc (More result about our model please check modeling: Chemical control model). We induced our engineered strain with gradients of ATc. Take 100μl culture to plate on LB agar plates containing appropriate concentration of antibody after 5 minutes, 30 minutes, 90 minutes of induce and counting Colony Forming Units the next day. The results fit the model within a range of ATc. So we choose a appropriate concentration of ATc (16μg/ml), aiming to maximize the expression of GSDMD-N275 and minimize the negative effect of bacteria growth.
1. Becskel, A. & Serrano, L. Engineering stability in gene networks by autoregulation. Nature 405, 590–593 (2000).